Show notes
We have another episode in a series of discussions with well-vetted guests from companies that I feel my community would benefit from hearing aboutToday, I speak with Dr. Stephanie Venn Watson, a veterinary epidemiologist and the co-founder and co-CEO of Serafina Therapeutics. She has worked with the World Health Organization, DARPA, and the US Navy. She has over 70 patents and has authored more than 80 peer-reviewed scientific papers, and her discoveries have featured on NPR, Science Friday, BBC, NBC, and National Geographic. Her groundbreaking discoveries around the health benefits of CIn our conversation today, we explore longevity molecules and geno-protective molecules, why they matter, and how they work. We cover the basics of rapamycin and glucophage, then dig into the growing body of research on longevity and lifespan, specifically looking at CSince I have been taking CIN THIS EPISODE, YOU WILL LEARN:• The role C• C• What Dr. Venn-Watson’s animal studies revealed about the mechanisms of aging in humans• Why women in midlife become more vulnerable to shifts in immune quality and cellular resilience• The ways nutritional deficiencies can appear in blood markers long before symptoms develop• What occurs with red blood cell stability and aging markers when C• Which biomarkers are now being considered early indicators of biological aging• Formulation features of C• The multiple bodily systems that can benefit from supplementing with CConnect with Cynthia Thurlow Follow on X, Instagram & LinkedIn Check out Cynthia’s website Submit your questions to [email protected] Join other like-minded women in a supportive, nurturing community (The Midlife Pause/Cynthia Thurlow) https://www.facebook.com/groups/themidlifepause Cynthia’s Menopause Gut Book is on presale now! Cynthia’s Intermittent Fasting Transformation Book The Midlife Pause supplement line Fatty 15Connect with Dr. Stephanie Venn-Watson Fatty 15 Discover C Seraphina Therapeutics LinkedIn
